UnitedHealth Beats Estimates, Raises Annual Profit Outlook Amid Medical Cost Pressures

UnitedHealth Group reported third-quarter results that surpassed analyst expectations and lifted its full-year profit guidance on Tuesday, even as the nation’s largest private insurer navigates persistent medical cost pressures. The company stated it now anticipates fiscal 2026 adjusted earnings of at least $20.50 per share, an increase from its previous range of $19.50 to $20.

The healthcare giant’s strategic turnaround is showing signs of progress after three consecutive strong quarters. UnitedHealth has been working to stabilize profit margins by reducing membership in unprofitable segments, exiting unfavorable contracts, and increasing investments in artificial intelligence and value-based care models. These models compensate providers based on patient health outcomes and cost efficiency rather than the volume of services rendered.

“We continue to execute not only on the financial aspects of our business, but really doing them with a simpler approach and an approach that’s really focused on investing heavily in value-based care,” CFO Wayne DeVeydt told CNBC.

Financial Performance

For the quarter, UnitedHealth reported adjusted earnings per share of $4.69, significantly outperforming the $4.14 forecast from LSEG analysts. Revenue came in at $112.69 billion, beating the $111.40 billion estimate. Net income totaled $4.11 billion, or $4.56 per share, compared to $2.35 billion in the same period last year. Both its UnitedHealthcare insurance unit and Optum healthcare services division exceeded operating earnings estimates.

Managing Elevated Costs

While the results were strong, DeVeydt cautioned that medical costs remain higher than historical norms, a challenge affecting many insurers, particularly those managing Medicare Advantage plans. The company’s medical cost ratio—the percentage of premiums paid out for medical expenses—stood at 88.4%, better than the 89.9% analysts had projected.

DeVeydt noted that the independent dispute resolution process under the No Surprises Act is adding approximately 100 basis points to total medical costs. Additionally, expenses for inpatient care and specialty pharmacy drugs for cancer and rare diseases continue to run high.

Strategic Investments

To counter these cost trends, UnitedHealth is leveraging value-based care and AI tools. The company reported a 15% year-over-year decline in acute hospital admissions among its members, while home health admissions rose 10%, indicating a shift toward more cost-effective care settings. Furthermore, AI-powered ambient listening tools are being deployed to reduce administrative burdens on physicians, leading to a 27% increase in patient-led appointment scheduling.

DeVeydt expressed confidence that these initiatives will generate compounding benefits for medical cost management throughout the fourth quarter and into 2027.